{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:52:54Z","timestamp":1794293574339,"version":"4.9.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although the acylation modification (AM) significantly influences the development of lung adenocarcinoma (LUAD), the specific mechanisms of acylation modification in this context have not been widely researched. This investigation sought to discover novel therapeutic avenues related to acylation modification for the precision treatment of LUAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Multiomics consensus clustering was generated for 12 types of acylation modifications, including crotonylation, lactylation, succinylation, benzoylation, acetylation, malonylation, glutarylation, 2-hydroxyisobutyrylation, \u03b2-hydroxybutyrylation, palmitoylation, myristoylation, and prenylation. Then, we established a learning signature referred to as AM.score using machine learning from 1,720 LUAD patients, and was validated across 8 cohorts and in-house cohort. We conducted a thorough evaluation involving 9 distinct immunotherapy cohorts to assess the effectiveness of the AM.score in predicting responses to immunotherapy treatments. Finally, the function of ZDHHC18 in LUAD was conducted both\n                      <jats:italic>in vivo<\/jats:italic>\n                      and\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The developed AM.score demonstrated remarkable predictive capabilities in forecasting outcomes for LUAD, and outperformed currently utilized prognostic indicators specific to LUAD. Furthermore, the predictive power of AM.score was not confined to LUAD alone; it was validated across various categories of malignancies, showcasing its broad applicability in evaluating responses to immunotherapy. From a biological standpoint, the analysis revealed significant correlations between AM.score and various immunological parameters. Notably, higher levels of AM.score were associated with induced immune responses, which in turn were linked to characteristics commonly associated with immunologically hot tumors-those that can elicit a robust immune response. Comprehensive scRNA-seq and spatial transcriptomics analyses demonstrated that elevated AM.score was associated with increased cell malignancy. Then, ZDHHC18 has been recognized as an essential molecular element in the framework, and higher expression levels of ZDHHC18 was associated with poorer clinical outcomes in LUAD. Mechanistically, knockout ZDHHC18 simultaneously enhance strong immune responses that hinder LUAD progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AM.score functions as a crucial predictive biomarker, providing valuable insights into both prognosis and the suitability of immunotherapy for individual patients. Furthermore, the focus on targeting ZDHHC18 presents a promising avenue for improving the effectiveness of immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1802631","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:33:03Z","timestamp":1775539983000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Acylation modification mediated post-translational modifications learning signature reveals ZDHHC18 promotes progression of lung adenocarcinoma by attenuating immunocyte activation"],"prefix":"10.3389","volume":"17","author":[{"given":"Qifan","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Beidahuang Industry Group General Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfa","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","article-title":"Cancer statistics 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: Emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41392-022-01200-x","article-title":"Signaling pathways and targeted therapies in lung squamous cell carcinoma: Mechanisms and clinical trials","volume":"7","author":"Niu","year":"2022","journal-title":"Signal Transd Targ Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00979-8","article-title":"Immunotherapy for advanced-stage squamous cell lung cancer: The state of the art and outstanding questions","volume":"22","author":"Wang","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.582370","article-title":"Histone deacetylase inhibition in non-small cell lung cancer: Hype or hope","volume":"8","author":"Mamdani","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.149147","article-title":"Tumor PLA2G10 restrains CD4(+) T cell activation in lung adenocarcinoma via enhancing arachidonic acid secretion","volume":"334","author":"Tian","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103051","article-title":"Acyltransferase zinc finger DHHC-type containing 2 aggravates gastric carcinoma growth by targeting Nrf2 signaling: A mechanism-based multicombination bionic nano-drug therapy","volume":"70","author":"Liu","year":"2024","journal-title":"Redox Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217025","article-title":"LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma","volume":"595","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102448","article-title":"Therapeutic stress triggers tumor STAT1 acetylation to disarm immunotherapy","volume":"6","author":"Chiu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-2443","article-title":"Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients","volume":"22","author":"Parra","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.873532","article-title":"Prognostic significance of the loss of heterozygosity of KRAS in early-stage lung adenocarcinoma","volume":"12","author":"Khadse","year":"2022","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neo.2020.04.005","article-title":"An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis","volume":"22","author":"Hight","year":"2020","journal-title":"Neoplasia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/jto.0000000000000042","article-title":"Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients","volume":"9","author":"Der","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.375","article-title":"Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma","volume":"35","author":"Schabath","year":"2016","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.19.7053","article-title":"Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis","volume":"27","author":"Tomida","year":"2009","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1158\/2326-6066.cir-16-0019","article-title":"Somatic mutations and neoepitope homology in melanomas treated with CTLA-4 blockade","volume":"5","author":"Nathanson","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(13)70098-4","article-title":"Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy","volume":"31","author":"Ulloa-Montoya","year":"2013","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp Mol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13148-020-00907-4","article-title":"Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer","volume":"12","author":"Kim","year":"2020","journal-title":"Clin Epigenet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41598-019-57218-9","article-title":"Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Hwang","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41435-025-00362-2","article-title":"Post-translational acylation modulates immunosuppression and immunotherapy efficacy in hepatocellular carcinoma","volume":"26","author":"Li","year":"2025","journal-title":"Genes Immun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.15.297820","article-title":"MOVICS: an R package for multi-omics integration and visualization in cancer subtyping","volume":"36","author":"Lu","year":"2021","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00896-9","article-title":"Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics","volume":"54","author":"Zhu","year":"2022","journal-title":"Exp Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100620","article-title":"Distinct phenotypic states and spatial distribution of CD8(+) T cell clonotypes in human brain metastases","volume":"3","author":"Sudmeier","year":"2022","journal-title":"Cell Rep Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-024-02069-w","article-title":"Cancer, metastasis, and the epigenome","volume":"23","author":"Kiri","year":"2024","journal-title":"Mol Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101097","article-title":"Pathological implication of protein post-translational modifications in cancer","volume":"86","author":"Pan","year":"2022","journal-title":"Mol Aspects Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189507","article-title":"Novel insights in the diagnosis and treatment of non-small cell lung cancer: Post-translational modification of proteins","volume":"1881","author":"Sun","year":"2026","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151240","article-title":"Amino acids control blood glucose levels through mTOR signaling","volume":"101","author":"Fan","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/cells13090781","article-title":"Nuclear mTOR signaling orchestrates transcriptional programs underlying cellular growth and metabolism","volume":"13","author":"Zhao","year":"2024","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.20944\/preprints202507.2086.v1","article-title":"Mechanisms underlying muscle-related diseases and aging: Insights into pathophysiology and therapeutic strategies","volume":"4","author":"Fan","year":"2025","journal-title":"Muscles"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2026.1771707","article-title":"Molecular mechanisms underlying the lifespan and healthspan benefits of dietary restriction across species","volume":"17","author":"Fan","year":"2026","journal-title":"Front Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116811","article-title":"PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to \u03b2 cell function and metabolic disease","volume":"45","author":"Fan","year":"2026","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116851","article-title":"Cancer-associated fibroblast-derived extracellular vesicles deliver ATP6V1C1 to promote lung adenocarcinoma metastasis via the ID1-IGFBP3 axis","volume":"45","author":"Chen","year":"2026","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1708670","article-title":"P2RY13+ dendritic cells correlate with enhanced antigen presentation and lymphocyte activation in lung adenocarcinoma","volume":"12","author":"Lan","year":"2025","journal-title":"Front Med (Laus)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e012710","DOI":"10.1136\/jitc-2025-012710","article-title":"Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer","volume":"13","author":"Yao","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ccell.2023.07.012","article-title":"CD44(+) lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration","volume":"41","author":"Huang","year":"2023","journal-title":"Cancer Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-1183","article-title":"Single-cell analysis identifies NOTCH3-mediated interactions between stromal cells that promote microenvironment remodeling and invasion in lung adenocarcinoma","volume":"84","author":"Xiang","year":"2024","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217241","article-title":"Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions","volume":"604","author":"Gang","year":"2024","journal-title":"Cancer Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)01029-8","article-title":"New promises and challenges in the treatment of advanced non-small-cell lung cancer","volume":"404","author":"Meyer","year":"2024","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.11.023","article-title":"Biomarkers in lung cancer screening: Achievements, promises, and challenges","volume":"14","author":"Seijo","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115492","article-title":"Biosensors for the detection of lung cancer biomarkers: A review on biomarkers, transducing techniques and recent graphene-based implementations","volume":"237","author":"Lin","year":"2023","journal-title":"Bios Bioelect"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.13308","article-title":"Protein palmitoylation in cancer: molecular functions and therapeutic potential","volume":"17","author":"Zhou","year":"2023","journal-title":"Mol Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159593","article-title":"Unraveling the potential contribution of DHHC2 in cancer biology via untargeted metabolomics","volume":"1870","author":"Chaturvedi","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"B53","doi-asserted-by":"publisher","first-page":"cor3","DOI":"10.1091\/mbc.e08-09-0944_corr","article-title":"The hydrophobic cysteine-rich domain of SNAP25 couples with downstream residues to mediate membrane interactions and recognition by DHHC palmitoyl transferases","volume":"33","author":"Greaves","year":"2022","journal-title":"Mol Biol Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s42003-020-1063-5","article-title":"Dynamic palmitoylation events following T-cell receptor signaling","volume":"3","author":"Morrison","year":"2020","journal-title":"Commun Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:33:05Z","timestamp":1775539985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1802631"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s009","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s010","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s011","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s012","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s013","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s014","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802631.s015","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"article-number":"1802631"}}